Kaleido Biosciences

BiotechnologySeries CLexington, USkaleido.com

Latest round

Series C

Last raised

Jun 2018

Total raised

$161M

Investors

5

About Kaleido Biosciences

Kaleido Biosciences, Inc.Kaleido Biosciences, Inc. was founded in 2015 and is headquartered in Lexington, US. The company is engaged in providing innovative platforms for clinical trials and patient engagement.40 mn.Kaleido provides advanced platforms designed to streamline clinical trials and enhance patient engagement. Their solutions facilitate data management and address end-use cases such as drug development acceleration and effective patient recruitment.Kaleido's strategy for future growth includes the development of new product offerings aimed at enhancing clinical trial management and patient engagement.40 mn to support these initiatives. However, in April 2022, Kaleido announced the discontinuation of operations, which may affect these growth plans.

Who invested in Kaleido Biosciences

5 investors across 2 rounds

See all investors in Kaleido Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jun 25, 2018

    Amount

    $101M

    Investors

    Locked

  2. Series B

    Sep 18, 2017

    Amount

    $60M

    Investors

    Locked

Questions about Kaleido Biosciences

Who invested in Kaleido Biosciences?

Kaleido Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kaleido Biosciences raised?

Kaleido Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Kaleido Biosciences last raise money?

Kaleido Biosciences's most recent round on record is a Series C, in Jun 2018.

What does Kaleido Biosciences do?

Kaleido Biosciences is a biotechnology company.

Where is Kaleido Biosciences headquartered?

Kaleido Biosciences is headquartered in Lexington, US.

Which VCs invest in companies like Kaleido Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kaleido Biosciences's stage. Their profiles are linked below.

Raising like Kaleido Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.